Metraipolis › archive › dc_96fd7f04fe66
Cost-Effectiveness and Budget Impact Analysis of the Trivalent Adjuvanted Influenza Vaccine in People over 50 Years of Age for Argentina — Europe PMC PMID:41893764
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41893764
- DOI
- 10.3390/vaccines14030227
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T12:45:16.162Z
- SHA-256 of the archived text
8e51b2a81e442aafee6921cb297b0debb3c83d0a4f09a386d61f31c350529765- Stable URL of this page
https://metraipolis.com/documento/dc_96fd7f04fe66
How to cite
Cost-Effectiveness and Budget Impact Analysis of the Trivalent Adjuvanted Influenza Vaccine in People over 50 Years of Age for Argentina — Europe PMC PMID:41893764 — Europe PMC (en), https://europepmc.org/article/MED/41893764 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_96fd7f04fe66 (Metraipolis archive dc_96fd7f04fe66, sha256 8e51b2a81e442aafee6921cb297b0debb3c83d0a4f09a386d61f31c350529765)
BibTeX
@misc{dc96fd7f04fe66,
title = {Cost-Effectiveness and Budget Impact Analysis of the Trivalent Adjuvanted Influenza Vaccine in People over 50 Years of Age for Argentina — Europe PMC PMID:41893764},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41893764},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_96fd7f04fe66; sha256 8e51b2a81e442aafee6921cb297b0debb3c83d0a4f09a386d61f31c350529765},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41893764. Agents can read the archived copy with the MCP tool read_document.